44 related articles for article (PubMed ID: 7940659)
1. The importance of confirmatory assays in testing blood donors for human T-cell lymphotropic virus.
Martins ML; Barbosa-Stancioli EF; da Silva-Malta MCF; Nunes SM
Vox Sang; 2024 Mar; 119(3):257-264. PubMed ID: 38223953
[TBL] [Abstract][Full Text] [Related]
2. HTLV infection in blood donors from Mato Grosso do Sul state: a closer look at HTLV screening in Brazilian blood banks.
Amianti C; Bandeira LM; Romeiro JS; Nakao BRO; Vavas MTM; Domingos JA; de Oliveira Uehara SN; Motta-Castro ARC
Sci Rep; 2023 Sep; 13(1):14524. PubMed ID: 37667056
[TBL] [Abstract][Full Text] [Related]
3. Genetic typing and intrafamilial transmission of human T-lymphotropic virus type 1 in non-endemic areas of China.
Ji H; Chang L; Yan Y; Sun H; Liu Y; Wang L
Front Microbiol; 2023; 14():1288990. PubMed ID: 37920260
[TBL] [Abstract][Full Text] [Related]
4. Development and Validation of a Rapid Screening Test for HTLV-I IgG Antibodies.
Herrera BB; Mayoral R; Brites C
Viruses; 2022 Dec; 15(1):. PubMed ID: 36680167
[TBL] [Abstract][Full Text] [Related]
5. Detection of early phase human T-cell leukemia virus type 1 and 2 infection with an improved confirmatory test.
Sagara Y; Nakamura H; Satake M; Matsuzaki K
J Clin Virol; 2023 Nov; 168():105598. PubMed ID: 37748321
[TBL] [Abstract][Full Text] [Related]
6. Is there any Association Between Human Lymphotropic Virus Type I (HTLV-I) Infection and Systemic Lupus Erythematosus? An Original Research and Literature Review.
Shirdel A; Hashemzadeh K; Sahebari M; Rafatpanah H; Hatef M; Rezaieyazdi Z; Mirfeizi Z; Faridhosseini R
Iran J Basic Med Sci; 2013 Mar; 16(3):252-7. PubMed ID: 24470872
[TBL] [Abstract][Full Text] [Related]
7. International Retrovirology Association brings together scientists and clinicians to bridge discoveries about human T-lymphotropic viruses from the laboratory to clinical trials.
Murphy E; Jacobson S; Franchini G; Taylor GP; Hanchard B; Morgan O; Lairmore M
Retrovirology; 2005 Mar; 2():22. PubMed ID: 15796774
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of human T-cell lymphotropic virus-1/2 in Canada over 33 years: A unique contribution of blood donors to public health surveillance.
O'Brien SF; Ehsani-Moghaddam B; Goldman M; Osmond L; Fan W; Drews SJ
Can J Public Health; 2024 May; ():. PubMed ID: 38743354
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of the New Multi-HTLV Serological Assay: Improvement for HTLV-2 Detection.
Folgosi VÂ; Konminakis SV; Silva FDD; Leite Junior PD; Haziot MEJ; Oliveira ACP; Smid J; Zrein M; Salvador F; Casseb J
AIDS Res Hum Retroviruses; 2024 Mar; 40(3):134-140. PubMed ID: 37646414
[TBL] [Abstract][Full Text] [Related]
10. Clinical and Public Health Implications of Human T-Lymphotropic Virus Type 1 Infection.
Legrand N; McGregor S; Bull R; Bajis S; Valencia BM; Ronnachit A; Einsiedel L; Gessain A; Kaldor J; Martinello M
Clin Microbiol Rev; 2022 Apr; 35(2):e0007821. PubMed ID: 35195446
[TBL] [Abstract][Full Text] [Related]
11. HTLV-1 infection: An emerging risk. Pathogenesis, epidemiology, diagnosis and associated diseases.
Eusebio-Ponce E; Anguita E; Paulino-Ramirez R; Candel FJ
Rev Esp Quimioter; 2019 Dec; 32(6):485-496. PubMed ID: 31648512
[TBL] [Abstract][Full Text] [Related]
12. Epidemiological Aspects and World Distribution of HTLV-1 Infection.
Gessain A; Cassar O
Front Microbiol; 2012; 3():388. PubMed ID: 23162541
[TBL] [Abstract][Full Text] [Related]
13. Can the level of immunosuppression in human immunodeficiency virus-infected patients affect the reliability of human T-cell lymphotropic virus type 2 serological diagnosis?
Bassani S; Toro C; Jiménez V; Rodés B; Soriano V
Clin Vaccine Immunol; 2006 Jan; 13(1):160-1. PubMed ID: 16426016
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of the INNO-LIA HTLV I/II assay for confirmation of human T-cell leukemia virus-reactive sera in blood bank donations.
Sabino EC; Zrein M; Taborda CP; Otani MM; Ribeiro-Dos-Santos G; Sáez-Alquézar A
J Clin Microbiol; 1999 May; 37(5):1324-8. PubMed ID: 10203479
[TBL] [Abstract][Full Text] [Related]
15. Screening for human T cell leukaemia/lymphoma virus among blood donors in Sweden: cost effectiveness analysis.
Tynell E; Andersson S; Lithander E; Arneborn M; Blomberg J; Hansson HB; Krook A; Nomberg M; Ramstedt K; Shanwell A; Bjorkman A
BMJ; 1998 May; 316(7142):1417-22. PubMed ID: 9572750
[TBL] [Abstract][Full Text] [Related]
16. Enhanced specificity of truncated transmembrane protein for serologic confirmation of human T-cell lymphotropic virus type 1 (HTLV-1) and HTLV-2 infections by western blot (immunoblot) assay containing recombinant envelope glycoproteins.
Varma M; Rudolph DL; Knuchel M; Switzer WM; Hadlock KG; Velligan M; Chan L; Foung SK; Lal RB
J Clin Microbiol; 1995 Dec; 33(12):3239-44. PubMed ID: 8586709
[TBL] [Abstract][Full Text] [Related]
17. Results of 1-year screening of donors in The Netherlands for human T-lymphotropic virus (HTLV) type I: significance of Western blot patterns for confirmation of HTLV infection.
Zaaijer HL; Cuypers HT; Dudok de Wit C; Lelie PN
Transfusion; 1994 Oct; 34(10):877-80. PubMed ID: 7940659
[TBL] [Abstract][Full Text] [Related]
18. Human T lymphotropic virus types I and II proviral sequences in Argentinian blood donors with indeterminate Western blot patterns.
Mangano AM; Remesar M; del Pozo A; Sen L
J Med Virol; 2004 Oct; 74(2):323-7. PubMed ID: 15332282
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of a p21e-spiked western blot (immunoblot) in confirming human T-cell lymphotropic virus type I or II infection in volunteer blood donors. The Retrovirus Epidemiology Donor Study Group.
Kleinman SH; Kaplan JE; Khabbaz RF; Calabro MA; Thomson R; Busch M
J Clin Microbiol; 1994 Mar; 32(3):603-7. PubMed ID: 8195365
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
